Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein

Journal of Hepatology

Volumn 31, Issue 1, 1999, Pages 123-132

  Yu, Dae Yeul ^a   Moon, Hyung Bae ^b   Son, Jin Kyong ^a   Jeong, Sangkyun ^a   Yu, Seong Lan ^a   Yoon, Heesik ^a   Han, Yong Mahn ^a   Lee, Chul Sang ^a   Park, Jung Sun ^a   Lee, Chul Ho ^a   Hyun, Byung Hwa ^a   Murakami, Seishi ^c   Lee, Kyung Kwang ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Wonkwang University   (South Korea)

^c NONE

Author keywords

HBV X gene; Hepatic tumors; Proliferating cell nuclear antigen; Transgenic mice

Indexed keywords

CYCLINE; MESSENGER RNA; PROTEIN X; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; HEPATITIS B VIRUS; HISTOPATHOLOGY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS;

EID: 0033058294     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80172-X     Document Type: Article

References (41)

1. Twu JS, Schlomer RH. Transcriptional transactivating function of hepatitis B virus. J Virol. 61:1987;3448-3453.
2. Twu JS, Chu K, Robinson WS. Hepatitis B virus X gene activates κB-like enhancer sequences in the long terminal repeat of immunodeficiency virus 1. Proc Natl Acad Sci USA. 86:1989;5168-5172.
3. Balsano C, Avantaggiati ML, Natoli G, De Marzio E, Will H, Perricaudet M, et al. Full-length and truncated versions of the hepatitis B virus X protein transactivate the c-myc protooncogene at the transcriptional level. Biochem Biophys Res Commun. 176:1991;985-992.
4. Twu JS, Lai MY, Chen DS, Robinson W. Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology. 192:1993;346-350.
5. Colgrove R, Simon G, Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol. 63:1989;4019-4026.
6. Wollersheim M, Debelka U, Hofschneider PH. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene. 3:1988;545-552.
7. Koike K, Akatsuka T, Miyamura T. Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene. Virology. 163:1988;233-235.
8. Koike K. Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology. 38:1995;134-142.
9. Matsubara K, Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med. 7:1990;243-260.
10. Diamantis ID, McGandy CE, Chen TJ, Liaw YF, Gudat F, Bianchi L. Hepatitis B X gene expression in hepatocellular carcinoma. J Hepatol. 15:1992;400-403.
11. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis surface antigen with hepatocellular carcinoma. Hepatology. 21:1995;313-321.
12. Zahm P, Hofschneider PH, Koshy R. The HBV X-ORF encodes a trans-activator: a potential factor in viral hepatocarcinogenesis. Oncogene. 3:1988;169-177.
13. Takada S, Koike K. Trans-activation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA. 87:1990;5628-5632.
14. Wollersheim M, Debelka U, Hofschneider PH. A trans-activating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene. 3:1998;545-552.
15. Balsano C, Billet O, Benoun M, Cavard C, Zider A, Grimber G, et al. Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol. 21:1994;103-109.
16. Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J. 9:1990;1137-1145.
17. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, et al. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH 3T3 cells. Jap J cancer Res. 80:1989;617-621.
18. Kim CM, Koike K, Saito I, Miyamura T, Jay G. Hepatitis B virus HBx gene induces liver cancer in transgenic mice. Nature. 351:1991;317-320.
19. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, et al. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19:1994;810-819.
20. Billet O, Grimber G, Levrero M, Seye KA, Briand P, Joulin V. In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J Virol. 69:1995;5912-5916.
21. Lee T-H, Finegold MJ, Shen RF, DeMayo JL, Woo SLC, Butel JS. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol. 64:1990;5939-5947.
22. Perfumo S, Amicone L, Colloca S, Giorgio M, Pozzi L, Tripodi M. Recognition efficiency of the hepatitis B virus polyadenylation signal is tissue specific in transgenic mice. J Virol. 66:1992;6819-6823.
23. Hogan B. Analysis of transgenic mice. Costantini F, Lacy E, . Manipulating the Mouse Embryos, 1st ed. Cold Spring Harbor Laboratory. 1986;174-176.
24. Bhan AK. Immuniperoxidase. Colvin RB, Bhan AK, McCluskey RT, . Diagnostic Immunopathology 1st ed. 1988;437-439 Raven Press, New York.
25. Cheong JH, Yi M, Lin Y, Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J. 14:1995;142-150.
26. Stanley LA, Devereux TR, Foley J, Lord PG, Maronpot RR, Orton TC, et al. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis. 13:1992;2427-2433.
27. Haviv I, Vaizel D, Shaul Y. The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol. 15:1995;1079-1085.
28. Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of ras and nuclear activator of transcription factors. EMBO J. 14:1995;4747-4757.
29. Aufiero B, Schneider RJ. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J. 9:1990;497-504.
30. Terradillos O, Billet O, Renard C-A, Levy R, Molina T, Briand P, et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene. 14:1997;395-404.
31. Feitelson MA, Zhu M, Duan LX, London WT. Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene. 8:1993;1109-1117.
32. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA. 91:1994;2230-2234.
33. Wall RJ, Bolt DJ, Frels WI, Hawk HW, King D, Pursel VG, et al. Transgenic farm animals: current state of the art. Agrobiotech News and Information. 2:1990;391-395.
34. Su Q, Schroder CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology. 27:1998;1109-1120.
35. Huang ZM, Yen TBS. Role of hepatitis B virus posttranscriptional regulatory element in intronless transcripts. Mol Cell Biol. 15:1994;3864-3869.
36. Frith CH, Ward JM. A morphological classification of profile and neoplastic hepatic lesions in mice. J Environ Pathol Tox. 3:1979;329-351.
37. Terada T, Nakanuma Y. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen. Cancer. 70:1992;591-598.
38. Drinkwater NR. Genetic control of hepatocarcinogenesis in inbred mice. Colburn NH, . Genes and signal transduction in multistage carcinogenesis. 1989;3-17 Dekker Inc, New York.
39. Homburger F, Russfield AB, Weisburger JH, Lim S, Chak SP, Weisburger EK. Aging changes in CD-1 HaM/ICR mice reared under standard laboratory conditions. J Natl Cancer Inst. 55:1975;37-43.
40. Percy DH, Jonas AM. Incidence of spontaneous tumors in CD-1 HaM/ICR mice. J Natl Cancer Inst. 46:1971;1045-1053.
41. Reifenberg K, Lohler J, Pudollek HP, Schmitteckert E, Spindler G, Kock J, et al. Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice. J Hepatol. 26:1997;119-130.